Get started

ONTX

On Balance Volume Use CasesTCON BNGO ONTX $TCON daily chart. January 16 2020 traded half it's float. March 2020 - Covid 3/16 to 8/27 Consolidation and huge block orders. Notice how regardless of the price, OBV is climbing higher and higher steps up, 1 step back 2 steps forward. Simple addition then subtraction rules apply and add and subtract green/red days volume for weighting. Then 8/17 TCON traded nearly twice it's float and laid dormant for close to a week. Despite many daily candles being red (faded) OBV jumped up from 12M to 30M overnight... $TCON then ran from $1.50s to $12.30 over the next few months. After look. $BNGO same story. After. $ONTX insane gap fill off a phase 3 failure. After. Overall, if obv doesn't look like this I rarely enter trades long term unless its an intraday position or possible swing. I'll have more examples coming. Good luck and I hope this was useful.
TEducation
by Todoubled23
Hot Penny Stock: Onconova Therapeutics (NASDAQ: $ONTX) 🔥🔥🔥Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its novel proprietary multi-kinase inhibitor ON 123300 to target CDK4/6 and other tyrosine kinases. The company's product candidate oral rigosertib, which is in Phase 1 study of rigosertib in combination with a PD-1 inhibitor for patients with progressive K-Ras mutated non-small cell lung cancer; and in Phase 1b/2 for recessive dystrophic epidermolysis bullosa. In addition, it is involved in preclinical work investigating rigosertib in COVID-19. The company has a license agreement with SymBio Pharmaceuticals Limited; and license, development, and commercialization agreement with Pint International SA. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania.
OLong
by DEXWireNews
3
Onconova Therapeutics (NASDAQ: $ONTX) Looking Juicy This MorningOnconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova’s novel, proprietary multi-kinase inhibitor ON 123300 is planned to begin a dose-escalation and expansion Phase 1 trial in the U.S. in the first half of 2021, and a dose-escalation and expansion Phase 1 trial is currently underway in China. Onconova’s product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with advanced KRAS+ lung adenocarcinoma in combination with nivolumab. Onconova Therapeutics was incorporated in 1998 in Delaware and began trading on the NASDAQ stock exchange under the ticker symbol ONTX in July, 2013.
OLong
by Bullishcharts
21
ONTX - Huge long-term potentialFrom a high timeframe outlook, ONTX looks primed and ready to go. However, as a rule of thumb I do not chase up markets. Sure, the price can keep going up but there are ALWAYS other opportunities that can be capitalized upon with cleaner entries. A retest and continuation of the 0.382 fib would be the most aggressive and likely realistic entry. Failing that, a drop down to the 0.618 fib would be nice too. Good luck! Hit the LIKE button if you find my analysis valuable and want to support my channel. Follow to make sure you don't miss any future trade ideas.
OLong
by AndyTheKing
1
ONTX Back At Previous Support Now Resistance?"Shares of this cheap stock managed to make a move from just $0.26 on November 30th to highs of over $0.55 this week. Volume has also become a focus recently too as the second half of December saw some of the highest daily trading volumes of the 3rd and 4th quarters. What has been going on with ONTX? Last month, Onconova received permission from the FDA to study its drug, ON 123300. This is used for treating certain types of cancer. What’s important to note is what the company’s CEO said and the milestones he gave. Specifically, Steven Fruchtman said, “We are advancing the process to secure institutional review board approval, and affirm our expectation that the first patient will be enrolled during the first half of 2021.” Interested to see if there's enough momo to get it above this level Source: Top Penny Stocks To Buy Under $1 On Robinhood This Week
O
by PennyStocks101
ONTX About to fly watch money inflow and volume** (First real analysis sharing with people, open to all criticism and other ideas to bounce back and forth) Watch morning pop then drop to .382 fib (a,b,c pattern to next resistance) $.81 and big gap up from vwap (resistance top of previous cancel but after bull flag and big vwap bounce itll bust straight through i think* Next resistance 1.07$ level... Drip too $1.02 next levels to watch .... 1.65$ ( This may be a big fomo play when this goes watch it to go parabolic) then next levels to watch 1.9952 2.1700 After this broke trend and watch for steady bullish trend
OLong
by BullishBear1996
ONTX - Could Breakout, How Far?All, ONTX is overdue for a takeoff. Today it is at +30% premarket, but this is why you do TA and watch Volume at open. It will gap above both blue lines for support and .44/.45 are aboth huge support lines. My theory is simple it may sell off around .53. However, I would hold and wait for the rally at .39 or .44 to push back up to .70-.75. The question there becomes will it break or fail that area on second re test? ALSO FIRST THING IS FIRST WATCH THE MARKET BEFORE YOU BUY ANY STOCK. S&P / NASDAQ AND WATCH VOLUME ON INVERSE S&P ETFS.
OLong
by DigitalData